|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Edwards BK, Ward E and Kohler BA: Annual
report to the nation on the status of cancer, 1975–2006, featuring
colorectal cancer trends and impact of interventions (risk factors,
screening, and treatment) to reduce future rates. Cancer.
116:544–573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin JS, Perdue LA, Henrikson NB, Bean SI
and Blasi PR: Screening for Colorectal Cancer: Updated Evidence
Report and Systematic Review for the US Preventive Services Task
Force. JAMA. 325:1978–1998. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Knudsen AB, Rutter CM, Peterse EFP, Lietz
AP, Seguin CL, Meester RGS, Perdue LA, Lin JS, Siegel RL,
Doria-Rose VP, et al: Colorectal cancer screening: An updated
modeling study for the US preventive services task force. JAMA.
325:1998–2011. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen H, Li N, Ren J, Feng X, Lyu Z, Wei L,
Li X, Guo L, Zheng Z, Zou S, et al: Participation and yield of a
population-based colorectal cancer screening programme in China.
Gut. 68:1450–1457. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao M, Li H, Sun D, He S, Yu Y, Li J, Chen
H, Shi J, Ren J, Li N and Chen W: Cancer screening in China: The
current status, challenges, and suggestions. Cancer Lett.
506:120–127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen H, Lu B and Dai M: Colorectal cancer
screening in China: Status, challenges, and prospects-China, 2022.
China CDC Wkly. 4:322–328. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai QC, Yu ED, Xiao Y, Bai WY, Chen X, He
LP, Yang YX, Zhou PH, Jiang XL, Xu HM, et al: Derivation and
validation of a prediction rule for estimating advanced colorectal
neoplasm risk in average-risk Chinese. Am J Epidemiol. 175:584–593.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong MC, Lam TY, Tsoi KK, Hirai HW, Chan
VC, Ching JY, Chan FK and Sung JJ: A validated tool to predict
colorectal neoplasia and inform screening choice for asymptomatic
subjects. Gut. 63:1130–1136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sung JJY, Wong MCS, Lam TYT, Tsoi KKF,
Chan VCW, Cheung W and Ching JYL: A modified colorectal screening
score for prediction of advanced neoplasia: A prospective study of
5744 subjects. J Gastroenterol Hepatol. 33:187–194. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Streatfeild J, Hickson J, Austin SB,
Hutcheson R, Kandel JS, Lampert JG, Myers EM, Richmond TK,
Samnaliev M, Velasquez K, et al: Social and economic cost of eating
disorders in the United States: Evidence to inform policy action.
Int J Eat Disord. 54:851–868. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roerig JL, Steffen KJ, Mitchell JE and
Zunker C: Laxative abuse: Epidemiology, diagnosis and management.
Drugs. 70:1487–1503. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Linardon J: Rates of abstinence following
psychological or behavioral treatments for binge-eating disorder:
Meta-analysis. Int J Eat Disord. 51:785–797. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hazzard VM, Simone M, Austin SB, Larson N
and Neumark-Sztainer D: Diet pill and laxative use for weight
control predicts first-time receipt of an eating disorder diagnosis
within the next 5 years among female adolescents and young adults.
Int J Eat Disord. 54:1289–1294. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jacobs EJ and White E: Constipation,
laxative use, and colon cancer among middle-aged adults.
Epidemiology. 9:385–3891. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Watanabe T, Nakaya N, Kurashima K,
Kuriyama S, Tsubono Y and Tsuji I: Constipation, laxative use and
risk of colorectal cancer: The Miyagi Cohort Study. Eur J Cancer.
40:2109–2115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Citronberg JS, Hardikar S, Phipps A,
Figueiredo JC and Newcomb P: Laxative type in relation to
colorectal cancer risk. Ann Epidemiol. 28:739–741. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Charlton RA, Snowball JM, Bloomfield K and
de Vries CS: Colorectal cancer risk reduction following macrogol
exposure: A cohort and nested case control study in the UK. PLoS
One. 8:e832032013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Citronberg J, Kantor ED, Potter JD and
White E: A prospective study of the effect of bowel movement
frequency, constipation, and laxative use on colorectal cancer
risk. Am J Gastroenterol. 109:1640–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kune GA, Kune S, Field B and Watson LF:
The role of chronic constipation, diarrhea, and laxative use in the
etiology of large-bowel cancer. Data from the Melbourne Colorectal
Cancer Study. Dis Colon Rectum. 31:507–512. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dukas L, Willett WC, Colditz GA, Fuchs CS,
Rosner B and Giovannucci EL: Prospective study of bowel movement,
laxative use, and risk of colorectal cancer among women. Am J
Epidemiol. 151:958–964. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nusko G, Schneider B, Schneider I,
Wittekind C and Hahn EG: Anthranoid laxative use is not a risk
factor for colorectal neoplasia: Results of a prospective case
control study. Gut. 46:651–655. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nascimbeni R, Donato F, Ghirardi M,
Mariani P, Villanacci V and Salerni B: Constipation, anthranoid
laxatives, melanosis coli, and colon cancer: A risk assessment
using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev.
11:753–757. 2002.PubMed/NCBI
|
|
24
|
Roberts MC, Millikan RC, Galanko JA,
Martin C and Sandler RS: Constipation, laxative use, and colon
cancer in a North Carolina population. Am J Gastroenterol.
98:857–864. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park JY, Mitrou PN, Luben R, Khaw KT and
Bingham SA: Is bowel habit linked to colorectal cancer?-Results
from the EPIC-Norfolk study. Eur J Cancer. 45:139–145. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Wu K, Cho E, Ma J, Chan AT, Gao
X, Willett WC, Fuchs CS and Giovannucci EL: Prospective cohort
studies of bowel movement frequency and laxative use and colorectal
cancer incidence in US women and men. Cancer Causes Control.
24:1015–1024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLoS Med.
6:e10000972009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ioannidis JP: Interpretation of tests of
heterogeneity and bias in meta-analysis. J Eval Clin Pract.
14:951–957. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brenner H, Bouvier AM, Foschi R, Hackl M,
Larsen IK, Lemmens V, Mangone L and Francisci S; EUROCARE Working
Group, : Progress in colorectal cancer survival in Europe from the
late 1980s to the early 21st century: the EUROCARE study. Int J
Cancer. 131:1649–1658. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simin J, Fornes R and Liu Q: Antibiotic
use and risk of colorectal cancer: A systematic review and
dose-response meta-analysis. Br J Cancer. 123:1825–1832. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sobhani I, Tap J, Roudot-Thoraval F,
Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J and
Furet JP: Microbial dysbiosis in colorectal cancer (CRC) patients.
PLoS One. 6:e163932011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wong SH and Yu J: Gut microbiota in
colorectal cancer: Mechanisms of action and clinical applications.
Nat Rev Gastroenterol Hepatol. 16:690–704. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Francescone R, Hou V and Grivennikov SI:
Microbiome, inflammation, and cancer. Cancer J. 20:181–189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bush NG, Diez-Santos I, Abbott LR and
Maxwell A: Quinolones: Mechanism, lethality and their contributions
to antibiotic resistance. Molecules. 25:56620202
|
|
38
|
Lombardi N, Crescioli G, Maggini V,
Bellezza R, Landi I, Bettiol A, Menniti-Ippolito F, Ippoliti I,
Mazzanti G, Vitalone A, et al: Anthraquinone laxatives use and
colorectal cancer: A systematic review and meta-analysis of
observational studies. Phytother Res. 36:1093–1102. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hibberd AA, Lyra A, Ouwehand AC, Rolny P,
Lindegren H, Cedgård L and Wettergren Y: Intestinal microbiota is
altered in patients with colon cancer and modified by probiotic
intervention. BMJ Open Gastroenterol. 4:e0001452017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gagnière J, Raisch J, Veziant J, Barnich
N, Bonnet R, Buc E, Bringer MA, Pezet D and Bonnet M: Gut
microbiota imbalance and colorectal cancer. World J Gastroenterol.
22:501–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
van Gorkom BA, de Vries EG, Karrenbeld A
and Kleibeuker JH: Review article: Anthranoid laxatives and their
potential carcinogenic effects. Aliment Pharmacol Ther. 13:443–452.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dunnick JK and Hailey JR: Phenolphthalein
exposure causes multiple carcinogenic effects in experimental model
systems. Cancer Res. 56:4922–4926. 1996.PubMed/NCBI
|
|
43
|
Park Y, Hunter DJ, Spiegelman D, Bergkvist
L, Berrino F, van den Brandt PA, Buring JE, Colditz GA, Freudenheim
JL, Fuchs CS, et al: Dietary fiber intake and risk of colorectal
cancer: A pooled analysis of prospective cohort studies. JAMA.
294:2849–2857. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Alabaster O, Tang Z and Shivapurkar N:
Dietary fiber and the chemopreventive modelation of colon
carcinogenesis. Mutat Res. 350:185–197. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lipkin M, Reddy B, Newmark H and Lamprecht
SA: Dietary factors in human colorectal cancer. Annu Rev Nutr.
19:545–586. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Barker N, Ridgway RA, van Es JH, van de
Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR,
Sansom OJ and Clevers H: Crypt stem cells as the cells-of-origin of
intestinal cancer. Nature. 457:608–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
